Skip to Content

COVID-19 Pill Could Be Available Later This Year: Pfizer CEO

THURSDAY, April 29, 2021 -- A pill to treat COVID-19 is being developed by Pfizer and could be available by the end of the year, company CEO Albert Bourla says.

In March, Pfizer launched an early-stage clinical trial of a new antiviral drug for the coronavirus that causes COVID-19, CBS News reported. The drug reduces the production of enzymes the virus needs to multiply in human cells.

If clinical trials are successful and the U.S. Food and Drug Administration approves the drug, it could be available across the United States later in 2021, Bourla told CNBC on Tuesday, CBS News reported.

Last month, Mikael Dolsten, M.D., chief scientific officer and president, worldwide research, development, and medical of Pfizer, said it is possible that the new drug could be prescribed "at the first sign of infection, without requiring that patients are hospitalized or in critical care."

CBS News Article

© 2021 HealthDay. All rights reserved.

Read this next

New Heart Failure Diagnosed in Hospitalized COVID-19 Patients

FRIDAY, May 14, 2021 -- Patients hospitalized with COVID-19 may be at risk for developing new heart failure, according to a research letter published in the May 4 issue of the...

CDC: COVID-19 Vaccine Can Be Given Along With Other Shots

THURSDAY, May 13, 2021 -- The U.S. Centers for Disease Control and Prevention said Wednesday that COVID-19 vaccines can be given along with other childhood shots, CNN reported...

CDC: Fully Vaccinated Can Shed Masks in Most Outdoor, Indoor Settings

THURSDAY, May 13, 2021 -- Fully vaccinated Americans can now skip face masks and social distancing in most indoor or outdoor settings, the U.S. Centers for Disease Control and...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.